These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1040 related articles for article (PubMed ID: 3079665)

  • 1. Inhibitory effect of 3-hydroxybenzo(a)pyrene on the mutagenicity and tumorigenicity of (+/-)-7 beta, 8 alpha-dihydroxy-9 alpha, 10 alpha-epoxy-7,8,9,10-tetrahydrobenzo(a)pyrene.
    Huang MT; Wood AW; Chang RL; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1986 Feb; 46(2):558-66. PubMed ID: 3079665
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibition of the mutagenicity of bay-region diol epoxides of polycyclic aromatic hydrocarbons by naturally occurring plant phenols: exceptional activity of ellagic acid.
    Wood AW; Huang MT; Chang RL; Newmark HL; Lehr RE; Yagi H; Sayer JM; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(18):5513-7. PubMed ID: 6752950
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fjord- and bay-region diol-epoxides investigated for stability, SOS induction in Escherichia coli, and mutagenicity in Salmonella typhimurium and mammalian cells.
    Glatt H; Piée A; Pauly K; Steinbrecher T; Schrode R; Oesch F; Seidel A
    Cancer Res; 1991 Mar; 51(6):1659-67. PubMed ID: 1900215
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by phenolic plant flavonoids.
    Huang MT; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH
    Carcinogenesis; 1983 Dec; 4(12):1631-7. PubMed ID: 6360409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutagenicity and cytotoxicity of benzo(a)pyrene benzo-ring epoxides.
    Wood AW; Wislocki PG; Chang RL; Levin W; Lu AY; Yagi J; Hernandez O; Herina DM; Conney AH
    Cancer Res; 1976 Sep; 36(9 pt.1):3358-66. PubMed ID: 788899
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of the mutagenicity of bay-region diol-epoxides of polycyclic aromatic hydrocarbons by tannic acid, hydroxylated anthraquinones and hydroxylated cinnamic acid derivatives.
    Huang MT; Chang RL; Wood AW; Newmark HL; Sayer JM; Yagi H; Jerina DM; Conney AH
    Carcinogenesis; 1985 Feb; 6(2):237-42. PubMed ID: 3918802
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenic and cell-transforming activities of triol-epoxides as compared to other chrysene metabolites.
    Glatt H; Seidel A; Bochnitschek W; Marquardt H; Marquardt H; Hodgson RM; Grover PL; Oesch F
    Cancer Res; 1986 Sep; 46(9):4556-65. PubMed ID: 3524815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutagenicity of the enantiomers of the diastereomeric bay-region benz(a)anthracene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Yagi H; Thakker DR; van Bladeren PJ; Jerina DM; Conney AH
    Cancer Res; 1983 Dec; 43(12 Pt 1):5821-5. PubMed ID: 6357432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity and tumorigenicity of dihydrodiols, diol epoxides, and other derivatives of benzo(f)quinoline and benzo(h)quinoline.
    Kumar S; Sikka HC; Dubey SK; Czech A; Geddie N; Wang CX; LaVoie EJ
    Cancer Res; 1989 Jan; 49(1):20-4. PubMed ID: 2908847
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Relationship between benzo(a)pyrene-induced DNA base modification and frequency of reverse mutations in mutant strains of Salmonella typhimurium.
    Fahl WE; Scarpelli DG; Gill K
    Cancer Res; 1981 Sep; 41(9 Pt 1):3400-6. PubMed ID: 6266655
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Roles of individual human cytochrome P-450 enzymes in the bioactivation of benzo(a)pyrene, 7,8-dihydroxy-7,8-dihydrobenzo(a)pyrene, and other dihydrodiol derivatives of polycyclic aromatic hydrocarbons.
    Shimada T; Martin MV; Pruess-Schwartz D; Marnett LJ; Guengerich FP
    Cancer Res; 1989 Nov; 49(22):6304-12. PubMed ID: 2509067
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutagenicity of the enantiomers of the diastereomeric bay-region benzo(c)phenanthrene 3,4-diol-1,2-epoxides in bacterial and mammalian cells.
    Wood AW; Chang RL; Levin W; Thakker DR; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1984 Jun; 44(6):2320-4. PubMed ID: 6372992
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity of the bay-region diol-epoxides and other benzo-ring derivatives of dibenzo(a,h)pyrene and dibenzo(a,i)pyrene.
    Wood AW; Chang RL; Levin W; Ryan DE; Thomas PE; Lehr RE; Kumar S; Sardella DJ; Boger E; Yagi H; Sayer JM; Jerina DM; Conney AH
    Cancer Res; 1981 Jul; 41(7):2589-97. PubMed ID: 7018665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bacterial and mammalian cell mutagenicity of four optically active bay-region 3,4-diol-1,2-epoxides and other derivatives of the nitrogen heterocycle dibenz[c,h]acridine.
    Wood AW; Chang RL; Levin W; Kumar S; Shirai N; Jerina DM; Lehr RE; Conney AH
    Cancer Res; 1986 Jun; 46(6):2760-6. PubMed ID: 3516386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumorigenicity of the diastereomeric bay-region benzo(e)pyrene 9,10-diol-11,12-epoxides in newborn mice.
    Chang RL; Levin W; Wood AW; Lehr RE; Kumar S; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1981 Mar; 41(3):915-8. PubMed ID: 7459878
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tumorigenicity in newborn mice of fjord region and other sterically hindered diol epoxides of benzo[g]chrysene, dibenzo[a,l]pyrene (dibenzo[def,p]chrysene), 4H-cyclopenta[def]chrysene and fluoranthene.
    Amin S; Desai D; Dai W; Harvey RG; Hecht SS
    Carcinogenesis; 1995 Nov; 16(11):2813-7. PubMed ID: 7586203
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Species-specific enhancement by 7,8-benzoflavone of hepatic microsomal metabolism of benzo[e]pyrene 9,10-dihydrodiol to bay-region diol epoxides.
    Thakker DR; Levin W; Buening M; Yagi H; Lehr RE; Wood AW; Conney AH; Jerina DM
    Cancer Res; 1981 Apr; 41(4):1389-96. PubMed ID: 7194138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Benzo(e)pyrene-induced alterations in the metabolic activation of benzo(a)pyrene and 7,12-dimethylbenz(a)anthracene by hamster embryo cells.
    Baird WM; Salmon CP; Diamond L
    Cancer Res; 1984 Apr; 44(4):1445-52. PubMed ID: 6322978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mutagenicity and tumor-initiating activity of cyclopenta(c,d)pyrene and structurally related compounds.
    Wood AW; Levin W; Chang RL; Huang MT; Ryan DE; Thomas PE; Lehr RE; Kumar S; Koreeda M; Akagi H; Ittah Y; Dansette P; Yagi H; Jerina DM; Conney AH
    Cancer Res; 1980 Mar; 40(3):642-9. PubMed ID: 7471084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanism of the inhibition of mutagenicity of a benzo[a]pyrene 7,8-diol 9,10-epoxide by riboflavin 5'-phosphate.
    Wood AW; Sayer JM; Newmark HL; Yagi H; Michaud DP; Jerina DM; Conney AH
    Proc Natl Acad Sci U S A; 1982 Sep; 79(17):5122-6. PubMed ID: 6813854
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 52.